Fluoxetine ameliorates imbalance of redox homeostasis and inflammation in an acute kidney injury model

Journal of Physiology and Biochemistry

Volumn 70, Issue 4, 2014, Pages 925-934

  Aksu, Ugur ^a   Guner, Ibrahim ^a   Yaman, Onur M ^a   Erman, Hayriye ^a   Uzun, Duygu ^a   Sengezer Inceli, Meliha ^a   Sahin, Ahmet ^b   Yelmen, Nermin ^a   Gelisgen, Remisa ^a   Uzun, Hafize ^a   Sahin, Gulderen ^a  

^a ISTANBUL UNIVERSITY   (Turkey)

^b Asfarma International Pharmaceutical Marketing   (Turkey)

Author keywords

Acute kidney injury; Fluoxetine; Inflammation; Ischemia reperfusion; Oxidative stress

Indexed keywords

ANTIOXIDANT; COPPER ZINC SUPEROXIDE DISMUTASE; CREATININE; FLUOXETINE; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 6; LIPID HYDROPEROXIDE; MALONALDEHYDE; MYELOPEROXIDASE; SUPEROXIDE DISMUTASE; TUMOR NECROSIS FACTOR ALPHA; UREA; URIC ACID; ANTIINFLAMMATORY AGENT; CYTOKINE; PEROXIDASE;

ACUTE KIDNEY FAILURE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; ARTICLE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DRUG MECHANISM; FEMALE; INFLAMMATION; KIDNEY FUNCTION; KIDNEY PARENCHYMA; LIPID PEROXIDATION; NONHUMAN; OXIDATION REDUCTION STATE; OXIDATIVE STRESS; RAT; UREA BLOOD LEVEL; ACUTE KIDNEY INJURY; ANIMAL; DRUG EFFECTS; DRUG SCREENING; ISCHEMIA; KIDNEY; MALE; METABOLISM; OXIDATION REDUCTION REACTION; PHYSIOLOGY; REPERFUSION INJURY; SPRAGUE DAWLEY RAT; VASCULARIZATION;

ACUTE KIDNEY INJURY; ANIMALS; ANTI-INFLAMMATORY AGENTS; ANTIOXIDANTS; CYTOKINES; DRUG EVALUATION, PRECLINICAL; FLUOXETINE; ISCHEMIA; KIDNEY; MALE; OXIDATION-REDUCTION; OXIDATIVE STRESS; PEROXIDASE; RATS, SPRAGUE-DAWLEY; REPERFUSION INJURY;

EID: 84911930918     PISSN: 11387548     EISSN: 18778755     Source Type: Journal    
DOI: 10.1007/s13105-014-0361-0     Document Type: Article

References (33)

1. Aivatidi C, Vourliotakis G, Georgopoulos S, Sigala F, Bastounis E, Papalambros E (2011) Oxidative stress during abdominal aortic aneurysm repair biomarkers and antioxidant’s protective effect: a review. Eur Rev Med Pharmacol Sci 153:245–252
2. Aksu U, Demirci C, Ince C (2011) The pathogenesis of acute kidney injury and the toxic triangle of oxygen, reactive oxygen species and nitric oxide. Contrib Nephrol 174:119–128
3. Alamdari DH, Ghayour-Mobarhan M, Tavallaie S, Parizadeh MR, Moohebati M, Ghafoori F, Kazemi-Bajestani SM, Paletas K, Pegiou T, Koliakos G (2008) Prooxidant-antioxidant balance as a new risk factor in patients with angiographically defined coronary artery disease. Clin Biochem 41:375–380
4. Benzie IF, Strain JJ (1999) Ferric reducing/antioxidant power assay: direct measure of total antioxidant activity of biological fluids and modified version for simultaneous measurement of total antioxidant power and ascorbic acid concentration. Methods Enzymol 299:15–27
5. Buege JA, Aust SD (1978) Microsomal lipid peroxidation. Methods Enzymol 52:302–310
6. Butterfield TA, Best TM, Merrick MA (2006) The dual roles of neutrophils and macrophages in inflammation: a critical balance between tissue damage and repair. J Athl Train 41:457–465
7. Chatterjee PK (2007) Novel pharmacological approaches to the treatment of renal ischemia-reperfusion injury: a comprehensive review. Naunyn Schmiedebergs Arch Pharmacol 376(1–2):1–43
8. Guner I, Yaman MO, Aksu U, Uzun D, Erman H, Inceli M, Gelisgen R, Yelmen N, Uzun H, Sahin G (2014) The effect of fluoxetine on ischemia-reperfusion following aortic surgery in a rat model. J Surg Res 189(1):96–105. doi:10.1016/j.jss.2014.02.033
9. Han DD, Wang Y, Zhang XH, Liu JR, Wang HL (2012) Fluoxetine protects against monocrotaline-induced pulmonary arterial remodeling by inhibition of hypoxia-inducible factor-1α and vascular endothelial growth factor. Can J Physiol Pharmacol 90:445
10. Hüttemann M, Helling S, Sanderson TH, Sinkler C, Samavati L, Mahapatra G, Varughese A, Lu G, Liu J, Ramzan R, Vogt S, Grossman LI, Doan JW, Marcus K, Lee I (2012) Regulation of mitochondrial respiration and apoptosis through cell signaling: cytochrome c oxidase and cytochrome c in ischemia/reperfusion injury and inflammation. Biochim Biophys Acta 1817(4):598–609
11. Kim H, Li H, Yoo KY, Lee BH, Hwang IK, Won MH (2007) Effects of fluoxetine on ischemic cells and expressions in BDNF and some antioxidants in the gerbil hippocampal CA1 region induced by transient ischemia. Exp Neurol 204(2):748–758
12. Kirkova M, Tzvetanova E, Vircheva S, Zamfirova R, Grygier B, Kubera M (2010) Antioxidant activity of fluoxetine: studies in mice melanoma model. Cell Biochem Funct 28(6):497–502
13. Koch A, Pernow M, Barthuber C, Mersmann J, Zacharowski K, Grotemeyer D (2012) Systemic inflammation after aortic cross clamping is influenced by Toll-like receptor 2 preconditioning and deficiency. J Surg Res 178(2):833–841
14. Kolla N, Wei Z, Richardson JS, Li XM (2005) Amitriptyline and fluoxetine protect PC12 cells from cell death induced by hydrogen peroxide. J Psychiatry Neurosci 30:196
15. Lakhan SE, Kirchgessner A, Hofer M (2009) Inflammatory mechanisms in ischemic stroke: therapeutic approaches. J Transl Med 7:97
16. Li X, Mai J, Virtue A, Yin Y, Gong R, Sha X, Gutchigian S, Frisch A, Hodge I, Jiang X, Wang H, Yang XF (2012) IL-35 is a novel responsive anti-inflammatory cytokine—a new system of categorizing anti-inflammatory cytokines. PLoS One 7(3):e33628. doi:10.1371/journal.pone.0033628
17. Lim CM, Kim SW, Park JY, Kim C, Yoon SH, Lee JK (2009) Fluoxetine affords robust neuroprotection in the postischemic brain via its anti-inflammatory effect. J Neurosci Res 87(4):1037–1045
18. Liu T, Clark RK, McDonnell PC, Young PR, White RF, Barone FC, Feuerstein GZ (1994) Tumor necrosis factor-alpha expression in ischemic neurons. Stroke 25:1481–1488
19. Marcos E, Adnot S, Pham MH, Nosjean A, Raffestin B, Hamon M, Eddahibi S (2003) Serotonin transporter inhibitors protect against hypoxic pulmonary hypertension. Am J Respir Crit Care Med 168:487
20. Naito Y, Yoshikawa T, Matsuyama K, Yagi N, Arai M, Nakamura Y, Kaneko T, Yoshida N, Kondo M (1998) Neutrophils, lipid peroxidation, and nitric oxide in gastric reperfusion injury in rats. Free Radic Biol Med 24(3):494–502
21. Noiri E, Nakao A, Uchida K, Tsukahara H, Ohno M, Fujita T, Brodsky S, Goligorsky MS (2001) Oxidative and nitrosative stress in acute renal ischemia. Am J Physiol Renal Physiol 281(5):F948–F957
22. Nourooz-Zadeh J (1999) Ferrous ion oxidation in presence of xylenol orange for detection of lipid hydroperoxides in plasma. Methods Enzymol 300:58–62
23. Núñez MJ, Balboa J, Rodrigo E, Brenlla J, González-Peteiro M, Freire-Garabal M (2006) Effects of fluoxetine on cellular immune response in stressed mice. Neurosci Lett 396:247–251
24. Park Y, Hirose R, Dang K, Xu F, Behrends M, Tan V, Roberts JP, Niemann CU (2008) Increased severity of renal ischemia-reperfusion injury with venous clamping compared to arterial clamping in a rat model. Surgery 143(2):243–251
25. Patel NS, Chatterjee PK, Chatterjee BE, Cuzzocrea S, Serraino I, Brown PA, Stewart KN, Mota-Filipe H, Thiemermann C (2002) TEMPONE reduces renal dysfunction and injury mediated by oxidative stress of the rat kidney. Free Radic Biol Med 33(11):1575–1589
26. Roumestan C, Michel A, Bichon F, Portet F, Detoc M, Henriquet C, Jaffuel D, Mathieu M (2007) Anti-inflammatory properties of desipramine and fluoxetine. Respiratory Research 3:8:35
27. Sahin G, Guner I, Yelmen N, Yaman O, Mengi M, Simsek G, Sipahi S (2011) Alterations of central hypercapnic respiratory response induced by acute central administration of serotonin re-uptake inhibitor, fluoxetine. Chin J Physiol 54(5):356–366
28. Sun Y, Oberley LW, Li Y (1988) A simple method for clinical assay of superoxide dismutase. Clin Chem 34:497–500
29. van der Poll T, Keogh CV, Guirao X, Buurman WA, Kopf M, Lowry SF (1997) Interleukin-6 gene-deficient mice show impaired defense against pneumococcal pneumonia. J Infect Dis 176(2):439–444. doi:10.1086/514062
30. Vinas JL, Sola A, Hotter G (2006) Mitochondrial NOS upregulation during renal I/R causes apoptosis in a peroxynitrite-dependent manner. Kidney Int 69(8):1403–1409
31. Wu Y, Wan J, Zhen WZ, Chen LF, Zhan J, Ke JJ, Zhang ZZ, Wang YL (2014) The effect of butorphanol postconditioning on myocardial ischaemia reperfusion injury in rats. Interact Cardiovasc Thorac Surg 18(3):308–312
32. Zafir A, Ara A, Banu N (2009) In vivo antioxidant status: a putative target of antidepressant action. Prog Neuropsychopharmacol Biol Psychiatry 33:220–228
33. Zou C, Ding X, Flaherty JH, Dong B (2013) Clinical efficacy and safety of fluoxetine in generalized anxiety disorder in Chinese patients. Neuropsychiatr Dis Treat 9:1661-1670. Epub 2013 Nov 1. Review